ResearcherShimane UniversityNo recent work listed

Yoko Hari

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5083470194. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2015: 1 paper

Papers 1

Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL. Co-author DOI 10.18632/oncotarget.5881 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Nanae Harashima · 1 shared paper, 2015 · strength 0.07
- Paper Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL. DOI 10.18632/oncotarget.5881 ↗
Yoshitsugu Tajima · 1 shared paper, 2015 · strength 0.07
- Paper Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL. DOI 10.18632/oncotarget.5881 ↗
Mamoru Harada · 1 shared paper, 2015 · strength 0.07
- Paper Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL. DOI 10.18632/oncotarget.5881 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.